UNIVERSAL BIOSENSORS INC. - Announcements

4.76%

2.2¢

Market Cap $6.557M

Technology Scientific & Technical Instruments

Universal Biosensors, Inc. is a biosensor company. The Company is engaged in developing... Universal Biosensors, Inc. is a biosensor company. The Company is engaged in developing and commercializing a range of biosensors in oenology (wine industry), human health including oncology, coagulation, women’s health and fertility, non-human and environmental testing using its platform technology and hand-held point-of-use devices. Its core technology consists of a disposable, multi-layer test strip, which incorporates an electrochemical sensing system using opposing electrodes that detect specific analytes in samples as small as a droplet. Its products include Sentia Wine Analyzer, Xprecia Prime Coagulation Analyzer, Hemostasis Reference Laboratory (HRL) and PETRACKR Veterinary Blood Glucose Monitoring System. HRL supports contract research organizations, central laboratories, early phase clinics, pharmaceutical/ biotechnology companies and academic researchers conducting clinical trials. HRL offers multiplex cytokine analysis on the MESO QuickPlex SQ 120MM technology platform.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

UBI	UBI Update	PRICE SENSITIVE	21/12/23	173.35KB	Share
UBI	Appendix 3Y - Graham McLean		12/12/23	222KB	Share
UBI	Change in substantial holding		08/12/23	261.45KB	Share
UBI	Universal Biosensors to host investor webinar and Q&A		31/10/23	913.49KB	Share
UBI	Q3 2023 Results Presentation - 30 September 2023	PRICE SENSITIVE	30/10/23	684.27KB	Share
UBI	Q3 2023 Results	PRICE SENSITIVE	30/10/23	404.55KB	Share
UBI	September 2023 Quarterly Activity Report and Appendix 4C	PRICE SENSITIVE	30/10/23	352.67KB	Share
UBI	Xprecia Prime 4U approved for Patient Self-Testing in Europe	PRICE SENSITIVE	04/10/23	149.03KB	Share
UBI	Change of Director's Interest Notice		13/09/23	576.97KB	Share
UBI	Approval and first order for Xprecia Prime in India	PRICE SENSITIVE	31/08/23	140.54KB	Share
UBI	UBI receives $4,495,137 under the R&D Tax Incentive Rebate	PRICE SENSITIVE	21/08/23	137.3KB	Share
UBI	Xprecia Prime tender win in Italy	PRICE SENSITIVE	09/08/23	136.63KB	Share
UBI	UBI Petrackr Update	PRICE SENSITIVE	08/08/23	136.71KB	Share
UBI	H1 2023 Results Webinar		02/08/23	575.11KB	Share
UBI	Half Year Results Presentation - 30 June 2023	PRICE SENSITIVE	31/07/23	379.89KB	Share
UBI	Appendix 4D and Half Year Results - 30 June 2023	PRICE SENSITIVE	31/07/23	686.13KB	Share
UBI	June 2023 Quarterly Activity Report and Appendix 4C	PRICE SENSITIVE	28/07/23	283.12KB	Share
UBI	Appendix 3Y - David Hoey		07/07/23	251.28KB	Share
UBI	Xprecia Business Update	PRICE SENSITIVE	03/07/23	160KB	Share
UBI	Results of 2023 Annual General meeting		22/05/23	202.38KB	Share
UBI	CEO's AGM address to Securityholders	PRICE SENSITIVE	22/05/23	588.71KB	Share
UBI	Q1 2023 Results	PRICE SENSITIVE	11/05/23	517.7KB	Share
UBI	UBI launches PETRACKR Diabetes product for dogs and cats	PRICE SENSITIVE	03/05/23	139.13KB	Share
UBI	Change in substantial holding		01/05/23	261.1KB	Share
UBI	Notification of cessation of securities - UBI		28/04/23	21.66KB	Share
UBI	March 2023 Quarterly Activity Report and Appendix 4C	PRICE SENSITIVE	28/04/23	286.8KB	Share
UBI	UBI launch sixth new Sentia Test	PRICE SENSITIVE	20/04/23	136.97KB	Share
UBI	Notice of Meeting/Proxy Statement		11/04/23	1.03MB	Share
UBI	UBI submits Xprecia Prime 510K Application to FDA	PRICE SENSITIVE	24/03/23	136.35KB	Share
UBI	Appendix 3Y - Graham McLean		16/03/23	250.97KB	Share
UBI	FY2022 Corporate Governance Statement & Appendix 4G		14/03/23	580.35KB	Share
UBI	FY2022 Corporate Governance Statement and Appendix 4G		24/02/23	423.29KB	Share
UBI	UBI Investor Presentation FY2022	PRICE SENSITIVE	24/02/23	200.63KB	Share
UBI	Appendix 4E and Annual Report on Form 10-K FY2022	PRICE SENSITIVE	24/02/23	692.89KB	Share
UBI	UBI launch another new Sentia Test	PRICE SENSITIVE	21/02/23	135.97KB	Share
UBI	Change in substantial holding		08/02/23	427.73KB	Share
UBI	UBI makes first sales of Xprecia Prime in Europe	PRICE SENSITIVE	06/02/23	135.46KB	Share
UBI	UBI launches new product - Fructose Test for Sentia	PRICE SENSITIVE	30/01/23	136.71KB	Share
UBI	December 2022 Quarterly Activity Report and Appendix 4C	PRICE SENSITIVE	27/01/23	360.86KB	Share
UBI	UBI completes Xprecia Prime clinical trial in USA	PRICE SENSITIVE	23/01/23	135.4KB	Share
UBI	UBI appoints a new Chairman		16/01/23	156.79KB	Share
UBI	Application for quotation of securities - UBI		03/01/23	26.79KB	Share
UBI	Notification of cessation of securities - UBI		13/12/22	21.67KB	Share
UBI	Appendix 3Y - Graham McLean		13/12/22	251.02KB	Share
UBI	UBI receives $3.9M under the R&D Tax Incentive Rebate	PRICE SENSITIVE	21/11/22	166.9KB	Share
UBI	UBI's Cancer Biomarker work gets published by ACS Sensors	PRICE SENSITIVE	17/11/22	323.47KB	Share
UBI	Appendix 3Y - Craig Coleman		17/11/22	193.97KB	Share
UBI	UBI Investor Presentation	PRICE SENSITIVE	09/11/22	1.39MB	Share
UBI	Change of Registry Address		31/10/22	77.61KB	Share
UBI	Q3 2022 Results Presentation	PRICE SENSITIVE	27/10/22	1.14MB	Share
UBI	September 2022 Quarterly Activity Report and Appendix 4C	PRICE SENSITIVE	27/10/22	981.72KB	Share
UBI	Market Update	PRICE SENSITIVE	06/09/22	888.95KB	Share
UBI	Change of Director's Interest Notice		18/08/22	578.12KB	Share
UBI	Half Year Results Presentation - 30 June 2022	PRICE SENSITIVE	10/08/22	277.04KB	Share
UBI	Appendix 4D and Half year Results - 30 June 2022	PRICE SENSITIVE	10/08/22	997.64KB	Share
UBI	New distribution deals in Europe and Glucose Test launch	PRICE SENSITIVE	29/07/22	246.1KB	Share
UBI	June 2022 Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	28/07/22	403.8KB	Share
UBI	Form 605 - JM Financial Group Ltd and No Plan B Pty Ltd		11/07/22	146.04KB	Share
UBI	Notification of cessation of securities - UBI		30/06/22	21.67KB	Share
UBI	Becoming a substantial holder		24/06/22	573.81KB	Share
UBI	Appendix 3Y - Judith Smith		21/06/22	250.75KB	Share
UBI	Results of 2022 Annual General Meeting		21/06/22	216.79KB	Share
UBI	CEO's AGM Address to Securityholders	PRICE SENSITIVE	21/06/22	828.53KB	Share
UBI	Form 604 - JM Financial Group Ltd		17/06/22	172.97KB	Share
UBI	Appendix 3Y - Craig Coleman		17/06/22	193.65KB	Share
UBI	Ceasing to be a substantial holder		17/06/22	476.22KB	Share
UBI	Appendix 3Y - Graham McLean		01/06/22	262.81KB	Share
UBI	Form 604 - Jencay Capital Pty ltd		31/05/22	219.93KB	Share
UBI	Form 604 - Viburnum Funds Pty Ltd		27/05/22	309.38KB	Share
UBI	Appendix 3Y - Craig Coleman		27/05/22	196KB	Share
UBI	Universal Biosensors banks $25.2 million	PRICE SENSITIVE	27/05/22	163.38KB	Share
UBI	Appendix 2A Entitlement Offer		27/05/22	373.07KB	Share
UBI	Appendix 3G		27/05/22	383.41KB	Share
UBI	Results of Entitlement Offer	PRICE SENSITIVE	24/05/22	241.52KB	Share
UBI	Results of Special Meeting of Securityholders 23 May 2022	PRICE SENSITIVE	23/05/22	215.42KB	Share
UBI	Form 604 - Jencay Capital Pty Ltd		20/05/22	220.83KB	Share
UBI	Form 604 - JM Financial Group Ltd		18/05/22	177.58KB	Share
UBI	Fully Underwritten $20 million Entitlement Offer - Update	PRICE SENSITIVE	18/05/22	250.21KB	Share
UBI	Appendix 3Y - Graham McLean		13/05/22	250.25KB	Share
UBI	Appendix 3X - Graham McLean		13/05/22	200.11KB	Share
UBI	Appendix 2A		12/05/22	378.11KB	Share
UBI	Application of Foreign Ownership Restriction Facility	PRICE SENSITIVE	12/05/22	188.01KB	Share
UBI	Application for quotation of securities - UBI		06/05/22	25.05KB	Share
UBI	Notice of Meeting of Stockholders to be held on 23 May 2022		05/05/22	1.4MB	Share
UBI	Becoming a substantial holder		05/05/22	583.35KB	Share
UBI	Placement Cleansing Notice		02/05/22	259.54KB	Share
UBI	Q1 2022 Results	PRICE SENSITIVE	29/04/22	2.39MB	Share
UBI	March 2022 Quarterly Activity Report and Appendix 4C	PRICE SENSITIVE	29/04/22	321.67KB	Share
UBI	Notice of Meeting/Proxy Statement		29/04/22	831.66KB	Share
UBI	Appendix 2A		29/04/22	377.81KB	Share
UBI	Retail Entitlement Offer Booklet	PRICE SENSITIVE	29/04/22	2.99MB	Share
UBI	Update to Placement Timetable	PRICE SENSITIVE	29/04/22	194.77KB	Share
UBI	UBI successfully raises $6m via an Institutional Placement	PRICE SENSITIVE	21/04/22	188.67KB	Share
UBI	Update - Proposed issue of securities - UBI		21/04/22	37.35KB	Share
UBI	Clarification Regarding Entitlement Offer Timetable	PRICE SENSITIVE	20/04/22	236.41KB	Share
UBI	Notification to Ineligible Securityholders		20/04/22	174.53KB	Share
UBI	Notification to Eligible Securityholders		20/04/22	178.43KB	Share
UBI	Proposed issue of securities - UBI		20/04/22	30.32KB	Share
UBI	Proposed issue of securities - UBI		20/04/22	38.82KB	Share
UBI	Cleansing Notice		20/04/22	181.51KB	Share

UBI UBI Update
21/12/23	PRICE SENSITIVE	173.35KB	Share
UBI Appendix 3Y - Graham McLean
12/12/23		222KB	Share
UBI Change in substantial holding
08/12/23		261.45KB	Share
UBI Universal Biosensors to host investor webinar and Q&A
31/10/23		913.49KB	Share
UBI Q3 2023 Results Presentation - 30 September 2023
30/10/23	PRICE SENSITIVE	684.27KB	Share
UBI Q3 2023 Results
30/10/23	PRICE SENSITIVE	404.55KB	Share
UBI September 2023 Quarterly Activity Report and Appendix 4C
30/10/23	PRICE SENSITIVE	352.67KB	Share
UBI Xprecia Prime 4U approved for Patient Self-Testing in Europe
04/10/23	PRICE SENSITIVE	149.03KB	Share
UBI Change of Director's Interest Notice
13/09/23		576.97KB	Share
UBI Approval and first order for Xprecia Prime in India
31/08/23	PRICE SENSITIVE	140.54KB	Share
UBI UBI receives $4,495,137 under the R&D Tax Incentive Rebate
21/08/23	PRICE SENSITIVE	137.3KB	Share
UBI Xprecia Prime tender win in Italy
09/08/23	PRICE SENSITIVE	136.63KB	Share
UBI UBI Petrackr Update
08/08/23	PRICE SENSITIVE	136.71KB	Share
UBI H1 2023 Results Webinar
02/08/23		575.11KB	Share
UBI Half Year Results Presentation - 30 June 2023
31/07/23	PRICE SENSITIVE	379.89KB	Share
UBI Appendix 4D and Half Year Results - 30 June 2023
31/07/23	PRICE SENSITIVE	686.13KB	Share
UBI June 2023 Quarterly Activity Report and Appendix 4C
28/07/23	PRICE SENSITIVE	283.12KB	Share
UBI Appendix 3Y - David Hoey
07/07/23		251.28KB	Share
UBI Xprecia Business Update
03/07/23	PRICE SENSITIVE	160KB	Share
UBI Results of 2023 Annual General meeting
22/05/23		202.38KB	Share
UBI CEO's AGM address to Securityholders
22/05/23	PRICE SENSITIVE	588.71KB	Share
UBI Q1 2023 Results
11/05/23	PRICE SENSITIVE	517.7KB	Share
UBI UBI launches PETRACKR Diabetes product for dogs and cats
03/05/23	PRICE SENSITIVE	139.13KB	Share
UBI Change in substantial holding
01/05/23		261.1KB	Share
UBI Notification of cessation of securities - UBI
28/04/23		21.66KB	Share
UBI March 2023 Quarterly Activity Report and Appendix 4C
28/04/23	PRICE SENSITIVE	286.8KB	Share
UBI UBI launch sixth new Sentia Test
20/04/23	PRICE SENSITIVE	136.97KB	Share
UBI Notice of Meeting/Proxy Statement
11/04/23		1.03MB	Share
UBI UBI submits Xprecia Prime 510K Application to FDA
24/03/23	PRICE SENSITIVE	136.35KB	Share
UBI Appendix 3Y - Graham McLean
16/03/23		250.97KB	Share
UBI FY2022 Corporate Governance Statement & Appendix 4G
14/03/23		580.35KB	Share
UBI FY2022 Corporate Governance Statement and Appendix 4G
24/02/23		423.29KB	Share
UBI UBI Investor Presentation FY2022
24/02/23	PRICE SENSITIVE	200.63KB	Share
UBI Appendix 4E and Annual Report on Form 10-K FY2022
24/02/23	PRICE SENSITIVE	692.89KB	Share
UBI UBI launch another new Sentia Test
21/02/23	PRICE SENSITIVE	135.97KB	Share
UBI Change in substantial holding
08/02/23		427.73KB	Share
UBI UBI makes first sales of Xprecia Prime in Europe
06/02/23	PRICE SENSITIVE	135.46KB	Share
UBI UBI launches new product - Fructose Test for Sentia
30/01/23	PRICE SENSITIVE	136.71KB	Share
UBI December 2022 Quarterly Activity Report and Appendix 4C
27/01/23	PRICE SENSITIVE	360.86KB	Share
UBI UBI completes Xprecia Prime clinical trial in USA
23/01/23	PRICE SENSITIVE	135.4KB	Share
UBI UBI appoints a new Chairman
16/01/23		156.79KB	Share
UBI Application for quotation of securities - UBI
03/01/23		26.79KB	Share
UBI Notification of cessation of securities - UBI
13/12/22		21.67KB	Share
UBI Appendix 3Y - Graham McLean
13/12/22		251.02KB	Share
UBI UBI receives $3.9M under the R&D Tax Incentive Rebate
21/11/22	PRICE SENSITIVE	166.9KB	Share
UBI UBI's Cancer Biomarker work gets published by ACS Sensors
17/11/22	PRICE SENSITIVE	323.47KB	Share
UBI Appendix 3Y - Craig Coleman
17/11/22		193.97KB	Share
UBI UBI Investor Presentation
09/11/22	PRICE SENSITIVE	1.39MB	Share
UBI Change of Registry Address
31/10/22		77.61KB	Share
UBI Q3 2022 Results Presentation
27/10/22	PRICE SENSITIVE	1.14MB	Share
UBI September 2022 Quarterly Activity Report and Appendix 4C
27/10/22	PRICE SENSITIVE	981.72KB	Share
UBI Market Update
06/09/22	PRICE SENSITIVE	888.95KB	Share
UBI Change of Director's Interest Notice
18/08/22		578.12KB	Share
UBI Half Year Results Presentation - 30 June 2022
10/08/22	PRICE SENSITIVE	277.04KB	Share
UBI Appendix 4D and Half year Results - 30 June 2022
10/08/22	PRICE SENSITIVE	997.64KB	Share
UBI New distribution deals in Europe and Glucose Test launch
29/07/22	PRICE SENSITIVE	246.1KB	Share
UBI June 2022 Quarterly Activity Report & Appendix 4C
28/07/22	PRICE SENSITIVE	403.8KB	Share
UBI Form 605 - JM Financial Group Ltd and No Plan B Pty Ltd
11/07/22		146.04KB	Share
UBI Notification of cessation of securities - UBI
30/06/22		21.67KB	Share
UBI Becoming a substantial holder
24/06/22		573.81KB	Share
UBI Appendix 3Y - Judith Smith
21/06/22		250.75KB	Share
UBI Results of 2022 Annual General Meeting
21/06/22		216.79KB	Share
UBI CEO's AGM Address to Securityholders
21/06/22	PRICE SENSITIVE	828.53KB	Share
UBI Form 604 - JM Financial Group Ltd
17/06/22		172.97KB	Share
UBI Appendix 3Y - Craig Coleman
17/06/22		193.65KB	Share
UBI Ceasing to be a substantial holder
17/06/22		476.22KB	Share
UBI Appendix 3Y - Graham McLean
01/06/22		262.81KB	Share
UBI Form 604 - Jencay Capital Pty ltd
31/05/22		219.93KB	Share
UBI Form 604 - Viburnum Funds Pty Ltd
27/05/22		309.38KB	Share
UBI Appendix 3Y - Craig Coleman
27/05/22		196KB	Share
UBI Universal Biosensors banks $25.2 million
27/05/22	PRICE SENSITIVE	163.38KB	Share
UBI Appendix 2A Entitlement Offer
27/05/22		373.07KB	Share
UBI Appendix 3G
27/05/22		383.41KB	Share
UBI Results of Entitlement Offer
24/05/22	PRICE SENSITIVE	241.52KB	Share
UBI Results of Special Meeting of Securityholders 23 May 2022
23/05/22	PRICE SENSITIVE	215.42KB	Share
UBI Form 604 - Jencay Capital Pty Ltd
20/05/22		220.83KB	Share
UBI Form 604 - JM Financial Group Ltd
18/05/22		177.58KB	Share
UBI Fully Underwritten $20 million Entitlement Offer - Update
18/05/22	PRICE SENSITIVE	250.21KB	Share
UBI Appendix 3Y - Graham McLean
13/05/22		250.25KB	Share
UBI Appendix 3X - Graham McLean
13/05/22		200.11KB	Share
UBI Appendix 2A
12/05/22		378.11KB	Share
UBI Application of Foreign Ownership Restriction Facility
12/05/22	PRICE SENSITIVE	188.01KB	Share
UBI Application for quotation of securities - UBI
06/05/22		25.05KB	Share
UBI Notice of Meeting of Stockholders to be held on 23 May 2022
05/05/22		1.4MB	Share
UBI Becoming a substantial holder
05/05/22		583.35KB	Share
UBI Placement Cleansing Notice
02/05/22		259.54KB	Share
UBI Q1 2022 Results
29/04/22	PRICE SENSITIVE	2.39MB	Share
UBI March 2022 Quarterly Activity Report and Appendix 4C
29/04/22	PRICE SENSITIVE	321.67KB	Share
UBI Notice of Meeting/Proxy Statement
29/04/22		831.66KB	Share
UBI Appendix 2A
29/04/22		377.81KB	Share
UBI Retail Entitlement Offer Booklet
29/04/22	PRICE SENSITIVE	2.99MB	Share
UBI Update to Placement Timetable
29/04/22	PRICE SENSITIVE	194.77KB	Share
UBI UBI successfully raises $6m via an Institutional Placement
21/04/22	PRICE SENSITIVE	188.67KB	Share
UBI Update - Proposed issue of securities - UBI
21/04/22		37.35KB	Share
UBI Clarification Regarding Entitlement Offer Timetable
20/04/22	PRICE SENSITIVE	236.41KB	Share
UBI Notification to Ineligible Securityholders
20/04/22		174.53KB	Share
UBI Notification to Eligible Securityholders
20/04/22		178.43KB	Share
UBI Proposed issue of securities - UBI
20/04/22		30.32KB	Share
UBI Proposed issue of securities - UBI
20/04/22		38.82KB	Share
UBI Cleansing Notice
20/04/22		181.51KB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 2.2¢		Change 0.001(4.76%)		Mkt cap ! $6.557M

Open	High	Low	Value	Volume
2.2¢	2.2¢	2.0¢	$960	45.43K

Buyers (Bids)

No.	Vol.	Price($)
6	3615135	2.0¢

Sellers (Offers)

Price($)	Vol.	No.
2.2¢	6959	1

View Market Depth

No.	Vol.	Price($)
6	3615135	0.020
1	50000	0.019
1	60000	0.016
1	100000	0.015
1	214355	0.014

Price($)	Vol.	No.
0.022	6959	1
0.023	55115	1
0.024	46983	2
0.025	93000	1
0.026	300000	1

Last trade - 13.15pm 11/08/2025 (20 minute delay)


Last 2.2¢		Change 0.001 ( 1.79 %)
Open	High	Low	Volume
2.2¢	2.2¢	2.2¢	409
Last updated 12.38pm 11/08/2025 ?

UBI (ASX) Chart

UNIVERSAL BIOSENSORS INC. - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available